Intera Atlas
Run match
Sites / San Diego Clinical Trials
Is this you?

Request access for San Diego Clinical Trials with your @sdclinicaltrials.com work email. Intera will contact you to verify and set up your account — nothing auto-publishes.

Request account

San Diego Clinical Trials

Unclaimed profile

Independent Site Network · La Mesa, CA · ~1 sites

WebsiteLinkedInRank for protocol
Intera lens
ICP 2Lift (cardio sample) 0.20Recruit soph 0.29
Quality Scorecard (1–100)
Overall82Recruit67Ops83Sponsor96Ther84

Performance (observed)

Historical trials
400
Completed
232
Terminated/Withdrawn
58
Completion rate
80%
Active now
107
Phase 2
104
Phase 3
250
Realized enrollment
602,175
First study year
1993
Years active
33
Match confidence
high
Enrollment velocity (inf)
18,248

Therapeutic

Areas
Urology (hypogonadism / low testosterone); Phase II-IV
Specialties
Multi-therapeutic (Endocrinology/Men's Health, Phase I-IV)
Breadth (conditions)
391
Languages
English/Spanish
States
CA

Recruitment (web observed)

Recruitment pages
Yes
Advertises recruitment
Yes
SEO
Weak organic presence
Capability notes
Active recruitment for hypogonadism/sexual dysfunction trials

Relationships

Sponsors
Pfizer; AbbVie; National Institute of Allergy and Infectious Diseases (NIAID); Hoffmann-La Roche; Janssen Research & Development, LLC; Shire
CROs
Allucent; IQVIA Pty Ltd; IQVIA Pvt. Ltd; MacroGenics; Medpace, Inc.; PPD Development, LP
Partnerships
Alliance Clinical Network
Owner / parent
Private; medical director position since 2008

Capacity & people

Investigators
—
Coordinators
—
CEO
Unknown
VP Clinical Ops
Unknown
VP Site Ops
Unknown
VP Recruitment
Dr. Mo Bidair, MD (Medical Director; board-certified urology, UCSD Assistant Professor, 100+ publications)
Emails
Not provided (phone: 619-287-6000)

Tech & DCT

eSource
Yes
Builds tech
Unknown
Tech stack
Not disclosed
Recruiting visible
Y

Notes

Single-site urology specialist (La Mesa, CA) focused narrowly on hypogonadism/testosterone trials. Medical Director: Dr. Mo Bidair (Harvard grad, UCSD faculty, extensive urology research). However, extremely narrow therapeutic focus (essentially one indication). Single location. No visible tech infrastructure. Poor Intera fit—micro-focus, single site, no network or recruitment innovation. [Validated: 48 active recruiting cardiometabolic trials on ClinicalTrials.gov.]

Recommendation features (sample indication)

Ind fit 0.28Liftability 0.20Overall82

FUTURE MOAT: absolute enrollment rates, funnel CPR, measured SSU, screen-fail reasons.